Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;86:1147-1155

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pressley, J. C.
Right arrow Articles by Prystowsky, E. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pressley, J. C.
Right arrow Articles by Prystowsky, E. N.
Right arrowPubmed/NCBI databases
*Genetics Home Reference

Circulation, Vol 86, 1147-1155, Copyright © 1992 by American Heart Association


ARTICLES

Effect of Ebstein's anomaly on short- and long-term outcome of surgically treated patients with Wolff-Parkinson-White syndrome

JC Pressley, JM Wharton, AS Tang, JE Lowe, JJ Gallagher and EN Prystowsky
Department of Medicine, Duke University Medical Center, Durham, NC 27710.

BACKGROUND. Ebstein's anomaly is the most commonly occurring congenital abnormality associated with the Wolff-Parkinson-White (WPW) syndrome. However, the effects of Ebstein's anomaly on the risks and benefits of surgical ablation of accessory pathways in patients with WPW syndrome are unknown. METHODS AND RESULTS. This study compared the long-term outcome of 38 WPW patients with Ebstein's anomaly undergoing accessory pathway ablation to a reference population of 384 similarly treated patients without the anomaly. Ebstein's anomaly was mild in 21 patients (55%) and moderate-to-severe in 17 patients (45%). Sixteen patients (42%) required tricuspid valve surgery, and 23 (61%) had an atrial septal defect or patent foramen ovale repaired. Baseline clinical characteristics and preoperative clinical arrhythmias were similar in both groups. Ten-year survival was 92.4% and 91.2% for patients with and without Ebstein's anomaly, respectively (p = NS). During a mean follow-up of 6.2 +/- 3.8 and 5.3 +/- 3.6 years, 82% of patients with and 90% without Ebstein's anomaly had either clinically insignificant or no arrhythmias, and 18% versus 10% reported symptoms suggesting arrhythmias lasting longer than 1 minute, respectively. Atrial fibrillation was reduced postoperatively to 9% (p less than 0.001) in patients with and to 4% (p less than 0.001) in those without the anomaly. Fewer hospitalizations were reported postoperatively by 90% versus 96% of patients with and without Ebstein's anomaly; 9.4% versus 6.0% of patients were disabled at follow-up, respectively (p = NS). CONCLUSIONS. Patients with Ebstein's anomaly are improved significantly after accessory pathway ablation. The presence of this anomaly should not preclude accessory pathway ablation in these patients.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
H. Laks, D. Marelli, M. Plunkett, and J. Myers
Adult Congenital Heart Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 1431 - 1464.
[Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
L. Bockeria, E. Golukhova, M. Dadasheva, A. Revishvili, A. Levant, V. Bazaev, F. Rzaev, and T. Kakuchaya
Advantages and disadvantages of one-stage and two-stage surgery for arrhythmias and Ebstein's anomaly
Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 536 - 540.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Moons, K. Van Deyk, K. Marquet, E. Raes, L. De Bleser, W. Budts, and S. De Geest
Individual quality of life in adults with congenital heart disease: a paradigm shift
Eur. Heart J., February 1, 2005; 26(3): 298 - 307.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
P. Moons, K. Van Deyk, W. Budts, and S. De Geest
Caliber of Quality-of-Life Assessments in Congenital Heart Disease: A Plea for More Conceptual and Methodological Rigor
Arch Pediatr Adolesc Med, November 1, 2004; 158(11): 1062 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. J. Deal, C. Mavroudis, and C. L. Backer
Beyond Fontan conversion: surgical therapy of arrhythmias including patients with associated complex congenital heart disease
Ann. Thorac. Surg., August 1, 2003; 76(2): 542 - 554.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
H. Laks, D. Marelli, M. Plunkett, J. Odim, and J. Myers
Adult Congenital Heart Disease
Card. Surg. Adult, January 1, 2003; 2(2003): 1329 - 1358.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
S. M. Chauvaud, G. Brancaccio, and A. F. Carpentier
Cardiac arrhythmia in patients undergoing surgical repair of Ebstein's anomaly
Ann. Thorac. Surg., May 1, 2001; 71(5): 1547 - 1552.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A young man with tachycardia
Postgrad. Med. J., February 1, 2001; 77(904): 128f - 128.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
C. B. Overgaard, D. A. Harrison, S. C. Siu, W. G. Williams, G. D. Webb, and L. Harris
Outcome of previous tricuspid valve operation and arrhythmias in adult patients with congenital heart disease
Ann. Thorac. Surg., December 1, 1999; 68(6): 2158 - 2163.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Cappato, M. Schluter, C. Weiß, M. Antz, D. H. Koschyk, T. Hofmann, and K.-H. Kuck
Radiofrequency Current Catheter Ablation of Accessory Atrioventricular Pathways in Ebstein's Anomaly
Circulation, August 1, 1996; 94(3): 376 - 383.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Misaki, G. Watanabe, T. Iwa, Y. Watanabe, K. Mukai, M. Takahashi, H. Ohtake, and K. Yamamoto
SURGICAL TREATMENT OF PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ASSOCIATED EBSTEIN'S ANOMALY
J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1702 - 1707.
[Abstract] [Full Text]